Description
SARS-CoV-2 Antigen Test Kit (LFIA) detects the SARS-CoV-2 nucleocapsid antigens with colloidal gold immunochromatography using a double antibody sandwich assay. The test cassette contains (1) colloidal gold-labeled anti-SARS-CoV-2 Nucleocapsid Protein antibody, (2) one detection T line and one quality control C line fixed on a nitrocellulose membrane. T line is fixed with another anti-SARS-CoV-2 Nucleocapsid Protein antibody for detecting SARS-CoV-2. The quality control antibody is fixed on the C line. When the appropriate amount of test sample treated with lysis bu er is added to the sample well of the test cassette, the sample will move forward along the test strip via capillary action. If the sample contains SARS-CoV-2 nucleocapsid antigens and concentration is higher than the limit of detection, the antigens will bind to the colloidal gold-labeled anti-SARS-CoV-2 Nucleocapsid Protein antibod.
